These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 27411063

  • 41. Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike.
    Lee JH, Leaman DP, Kim AS, Torrents de la Peña A, Sliepen K, Yasmeen A, Derking R, Ramos A, de Taeye SW, Ozorowski G, Klein F, Burton DR, Nussenzweig MC, Poignard P, Moore JP, Klasse PJ, Sanders RW, Zwick MB, Wilson IA, Ward AB.
    Nat Commun; 2015 Sep 25; 6():8167. PubMed ID: 26404402
    [Abstract] [Full Text] [Related]

  • 42. Alterations in the immunogenic properties of soluble trimeric human immunodeficiency virus type 1 envelope proteins induced by deletion or heterologous substitutions of the V1 loop.
    Ching L, Stamatatos L.
    J Virol; 2010 Oct 25; 84(19):9932-46. PubMed ID: 20660181
    [Abstract] [Full Text] [Related]

  • 43. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities.
    Earl PL, Broder CC, Long D, Lee SA, Peterson J, Chakrabarti S, Doms RW, Moss B.
    J Virol; 1994 May 25; 68(5):3015-26. PubMed ID: 7512157
    [Abstract] [Full Text] [Related]

  • 44. HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
    LaBranche CC, McGuire AT, Gray MD, Behrens S, Kwong PDK, Chen X, Zhou T, Sattentau QJ, Peacock J, Eaton A, Greene K, Gao H, Tang H, Perez LG, Chen X, Saunders KO, Kwong PD, Mascola JR, Haynes BF, Stamatatos L, Montefiori DC.
    PLoS Pathog; 2018 Nov 25; 14(11):e1007431. PubMed ID: 30395637
    [Abstract] [Full Text] [Related]

  • 45. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
    Dupuy FP, Kant S, Barbé A, Routy JP, Bruneau J, Lebouché B, Tremblay C, Pazgier M, Finzi A, Bernard NF.
    mBio; 2019 Dec 17; 10(6):. PubMed ID: 31848282
    [Abstract] [Full Text] [Related]

  • 46. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein.
    Earl PL, Broder CC, Doms RW, Moss B.
    J Virol; 1997 Apr 17; 71(4):2674-84. PubMed ID: 9060620
    [Abstract] [Full Text] [Related]

  • 47. Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells.
    Anand SP, Prévost J, Baril S, Richard J, Medjahed H, Chapleau JP, Tolbert WD, Kirk S, Smith AB, Wines BD, Kent SJ, Hogarth PM, Parsons MS, Pazgier M, Finzi A.
    J Virol; 2019 Feb 01; 93(3):. PubMed ID: 30429344
    [Abstract] [Full Text] [Related]

  • 48. Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.
    Aljedani SS, Liban TJ, Tran K, Phad G, Singh S, Dubrovskaya V, Pushparaj P, Martinez-Murillo P, Rodarte J, Mileant A, Mangala Prasad V, Kinzelman R, O'Dell S, Mascola JR, Lee KK, Karlsson Hedestam GB, Wyatt RT, Pancera M.
    PLoS Pathog; 2021 Sep 01; 17(9):e1009543. PubMed ID: 34559844
    [Abstract] [Full Text] [Related]

  • 49. Highly mutated monoclonal antibody 3F2 targets a conformational and strain-restricted epitope in human immunodeficiency virus gp41 with significant antibody-dependent cell cytotoxicity.
    DeCotes D, Baron S, Hoffman J, Garrett M, Sojar H, Hicar MD.
    Arch Virol; 2022 Nov 01; 167(11):2193-2201. PubMed ID: 35871426
    [Abstract] [Full Text] [Related]

  • 50. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
    Mishra N, Sharma S, Dobhal A, Kumar S, Chawla H, Singh R, Das BK, Kabra SK, Lodha R, Luthra K.
    J Virol; 2020 Sep 15; 94(19):. PubMed ID: 32669335
    [Abstract] [Full Text] [Related]

  • 51. Induction of Tier 1 HIV Neutralizing Antibodies by Envelope Trimers Incorporated into a Replication Competent Vesicular Stomatitis Virus Vector.
    Bresk CA, Hofer T, Wilmschen S, Krismer M, Beierfuß A, Effantin G, Weissenhorn W, Hogan MJ, Jordan APO, Gelman RS, Montefiori DC, Liao HX, Schmitz JE, Haynes BF, von Laer D, Kimpel J.
    Viruses; 2019 Feb 15; 11(2):. PubMed ID: 30769947
    [Abstract] [Full Text] [Related]

  • 52. Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes.
    Leaman DP, Lee JH, Ward AB, Zwick MB.
    J Virol; 2015 Jul 15; 89(13):6725-45. PubMed ID: 25878116
    [Abstract] [Full Text] [Related]

  • 53. Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor.
    Alam SM, Cronin K, Parks R, Anasti K, Ding H, Go EP, Desaire H, Eaton A, Montefiori D, Sodroski J, Kappes J, Haynes BF, Saunders KO.
    J Virol; 2020 Oct 14; 94(21):. PubMed ID: 32817216
    [Abstract] [Full Text] [Related]

  • 54. Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library.
    Zhou M, Meyer T, Koch S, Koch J, von Briesen H, Benito JM, Soriano V, Haberl A, Bickel M, Dübel S, Hust M, Dietrich U.
    Eur J Immunol; 2013 Feb 14; 43(2):499-509. PubMed ID: 23180650
    [Abstract] [Full Text] [Related]

  • 55. Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability.
    Dubrovskaya V, Tran K, Ozorowski G, Guenaga J, Wilson R, Bale S, Cottrell CA, Turner HL, Seabright G, O'Dell S, Torres JL, Yang L, Feng Y, Leaman DP, Vázquez Bernat N, Liban T, Louder M, McKee K, Bailer RT, Movsesyan A, Doria-Rose NA, Pancera M, Karlsson Hedestam GB, Zwick MB, Crispin M, Mascola JR, Ward AB, Wyatt RT.
    Immunity; 2019 Nov 19; 51(5):915-929.e7. PubMed ID: 31732167
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies.
    McGuire AT, Dreyer AM, Carbonetti S, Lippy A, Glenn J, Scheid JF, Mouquet H, Stamatatos L.
    Science; 2014 Dec 12; 346(6215):1380-1383. PubMed ID: 25504724
    [Abstract] [Full Text] [Related]

  • 60. Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.
    Choudhry V, Zhang MY, Sidorov IA, Louis JM, Harris I, Dimitrov AS, Bouma P, Cham F, Choudhary A, Rybak SM, Fouts T, Montefiori DC, Broder CC, Quinnan GV, Dimitrov DS.
    Virology; 2007 Jun 20; 363(1):79-90. PubMed ID: 17306322
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.